Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  therapeutic testosterone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-10 of 10 for your search:
Start Over
Phase III Chemotherapy with Fluoxymesterone, Oxymetholone, Testosterone and Splenectomy for Myeloproliferative Disorders and Refractory Anemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: PVSG-2
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000349426, NCCTG-N02C3, N02C3, NCT00075855
Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0262, NCT00965341
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
Phase: Phase II
Type: Prevention
Status: Completed
Age: 21 to 48
Sponsor: NCI, Other
Protocol IDs: 02164, P30CA033572, CHNMC-IRB-02164, CDR0000355156, NCI-2011-00975, NCT00080756
Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 to 85
Sponsor: Other
Protocol IDs: ART2, NCT00497458
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: 09-008, NCT00853697
Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 99-115, P30CA008748, P01CA005826, MSKCC-99115, NCI-G00-1818, NCT00006044
Chemotherapy with Oxymetholone or Testosterone Enanthate for Resistant Anemias Due to Myeloproliferative Disorders
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PVSG-11
Chemotherapy with L-PAM, L-PAM/PRED, and Testosterone Enanthate for Multiple Myeloma
Phase: No phase specified
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-6501, EST-0465
Start Over